Rights and permissions
About this article
Cite this article
Concomitant use of erythromycin + CYP3A inhibitors should be avoided. React. Wkly. 1019, 3 (2004). https://doi.org/10.2165/00128415-200410190-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200410190-00005